250 related articles for article (PubMed ID: 31709686)
1. Vascular calcification is associated with Wnt-signaling pathway and blood pressure variability in chronic kidney disease rats.
Liao R; Wang L; Li J; Sun S; Xiong Y; Li Y; Han M; Jiang H; Anil M; Su B
Nephrology (Carlton); 2020 Mar; 25(3):264-272. PubMed ID: 31709686
[TBL] [Abstract][Full Text] [Related]
2. Vascular Calcification Exacerbates Abnormal Blood Pressure Variability in Chronic Kidney Disease: A "Two-Step" Study in Rats.
Xiong Y; Yu Y; Huang K; Liao R; Wang L; Zhang Z; Li J; Qin Z; Sun S; Li Y; Su B
Cardiorenal Med; 2023; 13(1):66-73. PubMed ID: 36774922
[TBL] [Abstract][Full Text] [Related]
3. Secreted Frizzled-Related Protein 5 Ameliorates Vascular Calcification in a Rat Model of Chronic Kidney Disease through the Wnt/β-Catenin Pathway.
Deng D; Han X; Diao Z; Liu W
Kidney Blood Press Res; 2021; 46(6):758-767. PubMed ID: 34469882
[TBL] [Abstract][Full Text] [Related]
4. Reduction of Secreted Frizzled-Related Protein 5 Drives Vascular Calcification through Wnt3a-Mediated Rho/ROCK/JNK Signaling in Chronic Kidney Disease.
Oh YJ; Kim H; Kim AJ; Ro H; Chang JH; Lee HH; Chung W; Jun HS; Jung JY
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429518
[TBL] [Abstract][Full Text] [Related]
5. MiR-93 inhibits the vascular calcification of chronic renal failure by suppression of Wnt/β-catenin pathway.
Peng J; Qin C; Tian SY; Peng JQ
Int Urol Nephrol; 2022 Jan; 54(1):225-235. PubMed ID: 34138419
[TBL] [Abstract][Full Text] [Related]
6. Sclerostin/Receptor Related Protein 4 and Ginkgo Biloba Extract Alleviates β-Glycerophosphate-Induced Vascular Smooth Muscle Cell Calcification By Inhibiting Wnt/β-Catenin Pathway.
Wang J; Qiu X; Xu T; Sheng Z; Yao L
Blood Purif; 2019; 47 Suppl 1(Suppl 1):17-23. PubMed ID: 30699436
[TBL] [Abstract][Full Text] [Related]
7. High phosphorus level leads to aortic calcification via β-catenin in chronic kidney disease.
Yao L; Sun YT; Sun W; Xu TH; Ren C; Fan X; Sun L; Liu LL; Feng JM; Ma JF; Wang LN
Am J Nephrol; 2015; 41(1):28-36. PubMed ID: 25634106
[TBL] [Abstract][Full Text] [Related]
8. Apelin: A novel inhibitor of vascular calcification in chronic kidney disease.
Han X; Wang LY; Diao ZL; Liu WH
Atherosclerosis; 2016 Jan; 244():1-8. PubMed ID: 26581047
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rb1 ameliorates CKD-associated vascular calcification by inhibiting the Wnt/β-catenin pathway.
Zhou P; Zhang X; Guo M; Guo R; Wang L; Zhang Z; Lin Z; Dong M; Dai H; Ji X; Lu H
J Cell Mol Med; 2019 Oct; 23(10):7088-7098. PubMed ID: 31423730
[TBL] [Abstract][Full Text] [Related]
10. Sclerostin is involved in osteogenic transdifferentiation of vascular smooth muscle cells in chronic kidney disease-associated vascular calcification with non-canonical Wnt signaling.
Xiao Q; Tang Y; Luo H; Chen S; Chen R; Yan Z; Pu L; Wang L; Li G; Li Y
Ren Fail; 2022 Dec; 44(1):1426-1442. PubMed ID: 36017689
[TBL] [Abstract][Full Text] [Related]
11. Bone Morphogenetic Proteins 2/4 Are Upregulated during the Early Development of Vascular Calcification in Chronic Kidney Disease.
Wei X; Wu W; Li L; Lin J; Liu Q; Gan L; Ou S
Biomed Res Int; 2018; 2018():8371604. PubMed ID: 29850574
[TBL] [Abstract][Full Text] [Related]
12. Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification.
Tatsumoto N; Yamada S; Tokumoto M; Eriguchi M; Noguchi H; Torisu K; Tsuruya K; Kitazono T
Am J Physiol Renal Physiol; 2015 Dec; 309(11):F967-79. PubMed ID: 26336165
[TBL] [Abstract][Full Text] [Related]
13. OGT knockdown counteracts high phosphate-induced vascular calcification in chronic kidney disease through autophagy activation by downregulating YAP.
Xu TH; Sheng Z; Li Y; Qiu X; Tian B; Yao L
Life Sci; 2020 Nov; 261():118121. PubMed ID: 32693242
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress contributes to vascular calcification in patients with chronic kidney disease.
Huang M; Zheng L; Xu H; Tang D; Lin L; Zhang J; Li C; Wang W; Yuan Q; Tao L; Ye Z
J Mol Cell Cardiol; 2020 Jan; 138():256-268. PubMed ID: 31866376
[TBL] [Abstract][Full Text] [Related]
15. Specific knockdown of WNT8b expression protects against phosphate-induced calcification in vascular smooth muscle cells by inhibiting the Wnt-β-catenin signaling pathway.
Tian BY; Yao L; Sheng ZT; Wan PZ; Qiu XB; Wang J; Xu TH
J Cell Physiol; 2019 Apr; 234(4):3469-3477. PubMed ID: 30461014
[TBL] [Abstract][Full Text] [Related]
16. Wnt1 inhibits vascular smooth muscle cell calcification by promoting ANKH expression.
Chen B; Zhao Y; Han D; Zhao B; Mao Y; Cui ZK; Chu YC; Feng L; Yin S; Wang CY; Wang X; Xu MJ; Zhao G
J Mol Cell Cardiol; 2019 Oct; 135():10-21. PubMed ID: 31356809
[TBL] [Abstract][Full Text] [Related]
17. Phospholipase D: A new mediator during high phosphate-induced vascular calcification associated with chronic kidney disease.
Skafi N; Abdallah D; Soulage C; Reibel S; Vitale N; Hamade E; Faour W; Magne D; Badran B; Hussein N; Buchet R; Brizuela L; Mebarek S
J Cell Physiol; 2019 Apr; 234(4):4825-4839. PubMed ID: 30207376
[TBL] [Abstract][Full Text] [Related]
18. Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats.
de Castro BBA; do Carmo WB; de Albuquerque Suassuna PG; Carminatti M; Brito JB; Dominguez WV; de Oliveira IB; Jorgetti V; Custodio MR; Sanders-Pinheiro H
Exp Biol Med (Maywood); 2018 May; 243(9):796-802. PubMed ID: 29763365
[TBL] [Abstract][Full Text] [Related]
19. Secreted Frizzled-Related Protein 5 Attenuates High Phosphate-Induced Calcification in Vascular Smooth Muscle Cells by Inhibiting the Wnt/ß-Catenin Pathway.
Deng D; Diao Z; Han X; Liu W
Calcif Tissue Int; 2016 Jul; 99(1):66-75. PubMed ID: 26895007
[TBL] [Abstract][Full Text] [Related]
20. Protection Effect of Exogenous Fibroblast Growth Factor 21 on the Kidney Injury in Vascular Calcification Rats.
Shi YC; Lu WW; Hou YL; Fu K; Gan F; Cheng SJ; Wang SP; Qi YF; Liu JH
Chin Med J (Engl); 2018 Mar; 131(5):532-538. PubMed ID: 29483386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
